S&P Capital IQ vs. EDGAR Online
S&P Capital IQ vs. EDGAR Online
Product | Rating | Most Used By | Product Summary | Starting Price |
---|---|---|---|---|
S&P Capital IQ | N/A | Capital IQ is a market intelligence software solution offered by S&P Global Market Intelligence, which is the result of McGraw Hill Financial's acquisition of SNL Financial. | N/A | |
EDGAR Online | N/A | EDGAR Online data brings together real-time SEC regulatory data and financial analytics across over 12,000 SEC and OTC filers. The offering transforms how firms ingest and analyze disclosure data in a timely, accurate, automated manner. Whether researching an investment, performing competitive analysis or preparing for an IPO, EDGAR Online products provide the ability to access actionable data on companies and industries. | N/A |
S&P Capital IQ | EDGAR Online | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Editions & Modules | No answers on this topic | No answers on this topic | ||||||||||||||
Offerings |
| |||||||||||||||
Entry-level Setup Fee | No setup fee | No setup fee | ||||||||||||||
Additional Details | — | — | ||||||||||||||
More Pricing Information |
S&P Capital IQ | EDGAR Online | |
---|---|---|
Top Pros | No answers on this topic | |
Top Cons |
| No answers on this topic |
S&P Capital IQ | EDGAR Online | |
---|---|---|
Small Businesses | No answers on this topic | No answers on this topic |
Medium-sized Companies | No answers on this topic | S&P Capital IQ Score 7.8 out of 10 |
Enterprises | Factiva Score 6.6 out of 10 | S&P Capital IQ Score 7.8 out of 10 |
All Alternatives | View all alternatives | View all alternatives |
S&P Capital IQ | EDGAR Online | |
---|---|---|
Likelihood to Recommend | 9.0 (7 ratings) | - (0 ratings) |
Likelihood to Renew | 10.0 (1 ratings) | - (0 ratings) |
S&P Capital IQ | EDGAR Online | |
---|---|---|
Likelihood to Recommend | S&P Global Inc. | OTC Markets Group No answers on this topic |
Pros | S&P Global Inc. | OTC Markets Group No answers on this topic |
Cons | S&P Global Inc. | OTC Markets Group No answers on this topic |
Likelihood to Renew | S&P Global Inc. | OTC Markets Group No answers on this topic |
Alternatives Considered | S&P Global Inc. | OTC Markets Group No answers on this topic |
Return on Investment | S&P Global Inc. | OTC Markets Group No answers on this topic |
ScreenShots |